-transparent.png){kind=logo}
Effect of captopril and thiorphan on the proliferation of human neoplastic cell lines and their influence on cytostatic activity of interferon alpha or cytotoxic activity of doxorubicin. 1995
Department of Clinical Pharmacology, Silesian Medical Academy, Katowice, Poland.
We have assessed the effect of thiorphan or captopril on proliferation of two human tumor cell lines, A549 and HL60 including their influence on the cytostatic activity of interferon alpha or doxorubicin. The results showed that captopril inhibits the proliferation of both A549 and HL60 cells lines but thiorphan has antiproliferative effect only on A549 cells in a dose-dependent manner. However, neither captopril nor thiorphan administered in combination with interferon alpha or doxorubicin enhanced cytotoxic potential of doxorubicin and cytostatic activity of interferon alpha.
Related Publications
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
January 1983,
Cancer letters,
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
September 2005,
Journal of experimental & clinical cancer research : CR,
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
January 1994,
Cancer letters,
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
January 2004,
Cancer letters,
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
July 2002,
Planta medica,
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
January 1985,
Journal of interferon research,
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
May 1991,
Cancer letters,
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
October 2019,
In vitro cellular & developmental biology. Animal,
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
January 1999,
Neoplasma,
J Kowalski, and
D Belowski, and
J Wielgus, and
B Gabryel, and
M Klin, and
Z S Herman
January 1998,
Anticancer research,
